MESA LABORATORIES INC /CO/
For the period ended Mar 31, 2026. Filed Jun 3, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Jun 3, 2026
MLAB$127.82-0.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
(In thousands, except per share data)
| Year Ended March 31, | |||
|---|---|---|---|
| 2026 | 2025 | 2024 | |
| Revenues: | |||
| Products | $203,392 | $198,395 | $176,796 |
| Services | 45,738 | 42,583 | 39,391 |
| Total revenues | 249,130 | 240,978 | 216,187 |
| Cost of revenues: | |||
| Cost of products | 64,612 | 60,441 | 57,200 |
| Cost of services | 26,248 | 29,667 | 25,737 |
| Total cost of revenues | 90,860 | 90,108 | 82,937 |
| Gross profit | 158,270 | 150,870 | 133,250 |
| Operating expense: | |||
| Selling | 40,793 | 41,683 | 38,625 |
| General and administrative, other than impairment of finite-lived intangible assets and goodwill | 78,658 | 73,333 | 72,867 |
| Research and development | 20,308 | 19,518 | 19,300 |
| Impairment of finite-lived intangible assets | - | - | 117,641 |
| Impairment of goodwill | - | - | 156,892 |
| Total operating expense | 139,759 | 134,534 | 405,325 |
| Operating income (loss) | 18,511 | 16,336 | (272,075) |
| Nonoperating expense (income): | |||
| Interest expense and amortization of debt issuance costs | 10,692 | 11,859 | 5,697 |
| Gain on extinguishment of convertible senior notes | - | (2,887) | - |
| Other (income) expense, net | (4,195) | 1,403 | (2,124) |
| Total nonoperating expense, net | 6,497 | 10,375 | 3,573 |
| Earnings (loss) before income taxes | 12,014 | 5,961 | (275,648) |
| Income tax expense (benefit) | 5,302 | 7,935 | (21,402) |
| Net income (loss) | $6,712 | $(1,974) | $(254,246) |
| Net earnings (loss) per share | |||
| Basic | $1.22 | $(0.36) | $(47.20) |
| Diluted | $1.21 | $(0.36) | $(47.20) |
| Weighted-average common shares outstanding | |||
| Basic | 5,514 | 5,421 | 5,386 |
| Diluted | 5,565 | 5,421 | 5,386 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.